FBC
CVS icon

Fairfield, Bush & Co’s CVS Health CVS Stock Holding History

Fairfield, Bush & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,456
Closed -$355K – 113
2024
Q1 		$355K Sell
4,456
-174
-4% -$13.3K 0.21% 83
2023
Q4 		$366K Sell
4,630
-778
-14% -$55.4K 0.21% 79
2023
Q3 		$378K Sell
5,408
-6,999
-56% -$496K 0.25% 81
2023
Q2 		$858K Buy
12,407
+7,001
+130% +$498K 0.24% 80
2023
Q1 		$402K Buy
5,406
+1
+0% +$84 0.14% 103
2022
Q4 		$504K Buy
5,405
+34
+0.6% +$3.28K 0.33% 64
2022
Q3 		$512K Sell
5,371
-799
-13% -$79.1K 0.36% 63
2022
Q2 		$572K Sell
6,170
-150
-2% -$14.6K 0.34% 65
2022
Q1 		$640K Sell
6,320
-137
-2% -$14.4K 0.32% 69
2021
Q4 		$666K Buy
6,457
+1
+0% +$92 0.32% 64
2021
Q3 		$548K Buy
6,456
+1
+0% +$84 0.18% 108
2021
Q2 		$539K Sell
6,455
-799
-11% -$65.4K 0.15% 107
2021
Q1 		$546K Buy
+7,254
New +$528K 0.16% 114
2016
Q4 		– Sell
-27,605
Closed -$2.46M – 148
2016
Q3 		$2.46M Sell
27,605
-18,390
-40% -$1.74M 0.8% 35
2016
Q2 		$4.4M Buy
45,995
+70
+0.2% +$6.98K 1.53% 25
2016
Q1 		$4.76M Buy
45,925
+5,070
+12% +$493K 1.7% 23
2015
Q4 		$3.99M Buy
40,855
+22,025
+117% +$2.16M 1.4% 29
2015
Q3 		$1.82M Buy
18,830
+16,075
+583% +$1.69M 0.8% 38
2015
Q2 		$289K Buy
2,755
+1,025
+59% +$105K 0.09% 137
2015
Q1 		$179K Buy
+1,730
New +$175K 0.05% 169
2013
Q4 		– Sell
-400
Closed -$22K – 158
2013
Q3 		$22K Hold
400
– – 0.01% 220
2013
Q2 		$23K Buy
+400
New +$23.2K 0.01% 203

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fairfield, Bush & Co's CVS Position: Q2 2024 in Review

Fairfield, Bush & Co sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,456 shares — an estimated $355K sold.

Fairfield, Bush & Co first reported a position in CVS in Q2 2013 and held it in 22 quarters. The position peaked at $4.76M in Q1 2016. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Fairfield, Bush & Co reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 4,456 CVS Health shares in Q2 2024, an estimated $355K.
  • Fairfield, Bush & Co first reported a position in CVS Health in Q2 2013 and held it in 22 quarters.
  • Fairfield, Bush & Co's CVS Health position peaked at $4.76M in Q1 2016.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Fairfield, Bush & Co's 13F filing for Q2 2024, filed 15 Aug 2024.